Login / Signup

Gastroparesis treatment options metoclopramide and prucalopride: analysis of the FDA adverse event reporting system (FAERS) database.

Michael B AndrewsDouglas G Adler
Published in: Expert review of gastroenterology & hepatology (2024)
This FAERS database analysis shows post-marketing reports of ADRs from metoclopramide most frequently include tardive dyskinesia, dystonia, and tremor in addition to potentially fatal arrhythmias such as Torsade de pointes. Consumers of prucalopride may also be at risk of dystonia and other ADRs.
Keyphrases
  • adverse drug
  • deep brain stimulation
  • parkinson disease
  • early onset
  • drug induced
  • electronic health record
  • emergency department
  • congenital heart disease
  • data analysis